Liabilities of KalVista Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: KalVista Pharmaceuticals, Inc. quarterly Liabilities in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
KalVista Pharmaceuticals, Inc. Liabilities for the quarter ending 30 Sep 2025 was $322,932,000.
Source SEC data: View on sec.gov

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Liabilities (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$322,932,000			30 Sep 2025	10-Q	10 Nov 2025	2025	Q3
Q4 2024	$130,457,000			31 Dec 2024	10-Q	10 Nov 2025	2025	Q3
Q3 2016	$1,926,000	-$5,532,000	-74%	30 Sep 2016	10-Q	08 Nov 2016	2016	Q3
Q2 2016	$1,971,000	-$6,303,000	-76%	30 Jun 2016	10-Q	12 Aug 2016	2016	Q2
Q1 2016	$6,604,000	-$10,521,000	-61%	31 Mar 2016	10-Q	12 May 2016	2016	Q1
Q4 2015	$7,481,000	-$3,788,000	-34%	31 Dec 2015	10-Q	08 Nov 2016	2016	Q3
Q3 2015	$7,458,000			30 Sep 2015	10-Q	12 Nov 2015	2015	Q3
Q2 2015	$8,274,000			30 Jun 2015	10-Q	13 Aug 2015	2015	Q2
Q1 2015	$17,125,000			31 Mar 2015	10-Q	21 May 2015	2015	Q1
Q4 2014	$11,269,000			31 Dec 2014	10-K	30 Mar 2016	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.